Detected ·
T-Therapeutics Ltd
$133MSeries B
T-Therapeutics Ltd closed an oversubscribed $133M Series B to advance its TCR-CD3 bispecific T cell engager programs in oncology and autoimmune disease.
- Website
- —
- linkedin.com/company/93112302
- Amount
- $133 000 000 USD
- Stage
- Series B
- Event
- Funding round
- Detected
- 2026-11-06 00:05:34 UTC
- Signal ID
- e83af4e9-17a3-43f2-9d60-ed86eda93a8e
As the API returns it
{
"id": "e83af4e9-17a3-43f2-9d60-ed86eda93a8e",
"created_at": "2026-11-06T00:05:34.963296Z",
"company_name": "T-Therapeutics Ltd",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/93112302",
"event_type": "funding",
"funding_amount": 133000000,
"funding_currency": "USD",
"funding_stage": "series_b",
"message": "*T-Therapeutics Ltd closed an oversubscribed $133M Series B to advance its TCR-CD3 bispecific T cell engager programs in oncology and autoimmune disease.*"
}